Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects

Autor: Dominique Langin, Peter Arner, Signy Reynisdottir, Mia Klannemark, Cecilia Holm, Katrin Fredby, Valérie Large
Přispěvatelé: Karolinska University Hospital [Stockholm], Institut Louis Bugnard, Lund University [Lund], Large, Valerie
Rok vydání: 1999
Předmět:
Glycerol
Male
Adipose tissue
Hormone-sensitive lipase
Biochemistry
Body Mass Index
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Adipocyte
lipase
MESH: Obesity
Insulin
MESH: Cell Size
MESH: Aged
0303 health sciences
MESH: Sterol Esterase
MESH: Middle Aged
biology
Age Factors
Phosphodiesterase
Middle Aged
MESH: Gene Expression Regulation
Adipose Tissue
Female
catecholamines
MESH: Adipose Tissue
medicine.drug
Adult
medicine.medical_specialty
MESH: Mutation
mRNA
Lipolysis
enzymes
030209 endocrinology & metabolism
QD415-436
MESH: Insulin
MESH: Body Mass Index
03 medical and health sciences
Sex Factors
MESH: Sex Factors
MESH: Glycerol
Isoprenaline
Internal medicine
medicine
Humans
MESH: Lipolysis
Body Weights and Measures
Obesity
RNA
Messenger

Lipase
MESH: Body Weights and Measures
030304 developmental biology
MESH: RNA
Messenger

Aged
Cell Size
MESH: Age Factors
MESH: Humans
MESH: Adult
Cell Biology
Sterol Esterase
Enzyme assay
MESH: Male
[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition
chemistry
Gene Expression Regulation
Mutation
biology.protein
MESH: Female
[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
Zdroj: Journal of Lipid Research
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 1999, 40 (11), pp.2059-66
Karolinska Institutet
Europe PubMed Central
Journal of Lipid Research, Vol 40, Iss 11, Pp 2059-2065 (1999)
ISSN: 0022-2275
Popis: Decreased lipolytic effect of catecholamines in adipose tissue has repeatedly been demonstrated in obesity and may be a cause of excess accumulation of body fat. However, the mechanisms behind this lipolysis defect are unclear. The role of hormone-sensitive lipase was examined using abdominal subcutaneous adipocytes from 34 obese drug-free and otherwise healthy males or females and 14 non-obese control subjects. The enzyme catalyzes the rate-limiting step of the lipolysis pathway. The maximum lipolytic capacity of fat cells was significantly decreased in obesity when measured using either a non-selective beta-adrenergic receptor agonist (isoprenaline) or a phosphodiesterase resistant cyclic AMP analogue (dibutyryl cyclic AMP). Likewise, enzyme activity, protein expression, and mRNA of hormone-sensitive lipase were significantly decreased in adipocytes of obese subjects. The findings were not influenced by age or gender. The data suggest that a decreased expression of hormone-sensitive lipase in subcutaneous fat cells, which in turn causes decreased enzyme function and impaired lipolytic capacity of adipocytes, is present in obesity. Impaired expression of the hormone-sensitive lipase gene might at least in part explain the enzyme defect.—Large, V., S. Reynisdottir, D. Langin, K. Fredby, M. Klannemark, C. Holm, and P. Arner. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J. Lipid Res. 1999. 40: 2059–2065.
Databáze: OpenAIRE